Kerong Chen, Sitong Zhou, Shiyu Lu, Yuliang Qin, Xinyao Li, Yi Li, Tianyun Liu, Mei Zhang, Kun Xu, Hongping Shi, Xiaoman Lv, Kai Yuan, Hongling Shi, Dongdong Qin
{"title":"A systematic review of the efficacy of repetitive transcranial magnetic stimulation in treating dysarthria in patients with Parkinson's disease.","authors":"Kerong Chen, Sitong Zhou, Shiyu Lu, Yuliang Qin, Xinyao Li, Yi Li, Tianyun Liu, Mei Zhang, Kun Xu, Hongping Shi, Xiaoman Lv, Kai Yuan, Hongling Shi, Dongdong Qin","doi":"10.3389/fnagi.2025.1501640","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To analyze the literature on the efficacy of repetitive transcranial magnetic stimulation (rTMS) in treating dysarthria in patients with Parkinson's disease (PD) and provide a reference for targeted clinical treatment of dysarthria in PD patients.</p><p><strong>Methods: </strong>A systematic search was conducted in English and Chinese databases, including Embase, Cochrane, Medline, PubMed, CNKI, Wanfang, Chinese Biomedical Literature Database, and VIP Database, for relevant literature on rTMS treatment for dysarthria in PD patients. The search timeframe was from the inception of each database to October 2023. Literature was screened according to inclusion and exclusion criteria. Two researchers extracted information on study subjects, age, intervention methods, intervention duration, intervention frequency, evaluation indicators, and intervention results from the included literature. The modified Jadad scale was used to evaluate the quality of the literature.</p><p><strong>Results: </strong>A total of seven studies were included, mainly focusing on the frequency, duration, and stimulation site of rTMS for dysarthria in PD patients. Six studies indicated that rTMS treatment improved dysarthria in PD patients.</p><p><strong>Conclusion: </strong>Repetitive transcranial magnetic stimulation has a positive effect on improving dysarthria in PD patients, but further research is needed to determine its efficacy.</p>","PeriodicalId":12450,"journal":{"name":"Frontiers in Aging Neuroscience","volume":"17 ","pages":"1501640"},"PeriodicalIF":4.1000,"publicationDate":"2025-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11841439/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Aging Neuroscience","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fnagi.2025.1501640","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"GERIATRICS & GERONTOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Objective: To analyze the literature on the efficacy of repetitive transcranial magnetic stimulation (rTMS) in treating dysarthria in patients with Parkinson's disease (PD) and provide a reference for targeted clinical treatment of dysarthria in PD patients.
Methods: A systematic search was conducted in English and Chinese databases, including Embase, Cochrane, Medline, PubMed, CNKI, Wanfang, Chinese Biomedical Literature Database, and VIP Database, for relevant literature on rTMS treatment for dysarthria in PD patients. The search timeframe was from the inception of each database to October 2023. Literature was screened according to inclusion and exclusion criteria. Two researchers extracted information on study subjects, age, intervention methods, intervention duration, intervention frequency, evaluation indicators, and intervention results from the included literature. The modified Jadad scale was used to evaluate the quality of the literature.
Results: A total of seven studies were included, mainly focusing on the frequency, duration, and stimulation site of rTMS for dysarthria in PD patients. Six studies indicated that rTMS treatment improved dysarthria in PD patients.
Conclusion: Repetitive transcranial magnetic stimulation has a positive effect on improving dysarthria in PD patients, but further research is needed to determine its efficacy.
期刊介绍:
Frontiers in Aging Neuroscience is a leading journal in its field, publishing rigorously peer-reviewed research that advances our understanding of the mechanisms of Central Nervous System aging and age-related neural diseases. Specialty Chief Editor Thomas Wisniewski at the New York University School of Medicine is supported by an outstanding Editorial Board of international researchers. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.